Dyslipidemia is a condition marked by irregularities in blood lipid levels, most notably total cholesterol and triglycerides. Low levels of high-density lipoprotein cholesterol (HDL-C) and high levels of low-density lipoprotein cholesterol (LDL-C) are also alterations. Addressing dyslipidemia is a crucial aspect of various practice guidelines, but there are notable disparities among these recommendations. Regrettably, these guidelines often encounter limited adherence within primary care settings. This lack of widespread compliance may be attributed to inadequacies in the qualifications of primary care healthcare staff, a lack of engagement with recent guidelines, and the imposition of unrealistic targets on patients, resulting in non-compliance with prescribed medications and follow-up recommendations. The Medline, Pubmed, Embase, NCBI, and Cochrane databases were searched for studies of patients with non-alcoholic fatty liver disease. Incidence, etiology, and management options were analyzed. Dyslipidemia emerges as a significant risk factor for cardiovascular disease, necessitating comprehensive management strategies. The collaborative efforts of healthcare professionals, particularly those in primary healthcare settings, are instrumental in identifying, managing, and educating individuals with dyslipidemia. This collective endeavor significantly contributes to the prevention and reduction of cardiovascular events, ultimately improving overall cardiovascular health outcomes.